Search
- Mar 4
Nuvalent's CEO on overcoming kinase resistance and selectivity for its precision oncology medicines
Jim Porter describes the chemistry that has led to early stage success against ALK and ROS1.
Also look for unique social pages for BiotechTV U.
The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants